These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29905019)

  • 1. I-123 DaTscan SPECT Brain Imaging in Parkinsonian Syndromes: Utility of the Putamen-to-Caudate Ratio.
    Matesan M; Gaddikeri S; Longfellow K; Miyaoka R; Elojeimy S; Elman S; Hu SC; Minoshima S; Lewis D
    J Neuroimaging; 2018 Nov; 28(6):629-634. PubMed ID: 29905019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
    Im JH; Chung SJ; Kim JS; Lee MC
    J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome.
    Warhadpande DS; Huo J; Libling WA; Stuehm C; Najafi B; Sherman S; Lei H; Roveda JM; Kuo PH
    Sensors (Basel); 2022 Jul; 22(13):. PubMed ID: 35808551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT.
    Neill M; Fisher JM; Brand C; Lei H; Sherman SJ; Chou YH; Kuo PH
    Tomography; 2021 Dec; 7(4):980-989. PubMed ID: 34941653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.
    Isaacson SH; Fisher S; Gupta F; Hermanowicz N; Kremens DE; Lew MF; Marek K; Pahwa R; Russell DS; Seibyl J
    Expert Rev Neurother; 2017 Mar; 17(3):219-225. PubMed ID: 27813429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-Ioflupane dopamine transporter imaging (DaTSCAN) appearances in relation to emotional responsiveness, impulsivity and olfaction in suspected Parkinsonian syndrome.
    La Torre G; Herman AM; Jessop M; Abdula N; Crawshaw A; Begley P; Wroe E; Saha RA; Duka T; Dizdarevic S
    Nucl Med Commun; 2020 Nov; 41(11):1117-1127. PubMed ID: 32826621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Overview of
    Mercer MK; Revels JW; Blacklock LC; Banks KP; Johnson LS; Lewis DH; Kuo PH; Wilson S; Elojeimy S
    Radiographics; 2024 Feb; 44(2):e230133. PubMed ID: 38236751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.